Please login to the form below

Not currently logged in
Email:
Password:

Cardioxyl Pharma

This page shows the latest Cardioxyl Pharma news and features for those working in and with pharma, biotech and healthcare.

BMS agrees to buy Cardioxyl for heart failure drug

BMS agrees to buy Cardioxyl for heart failure drug

BMS agrees to buy Cardioxyl for heart failure drug. Willpay up to $2bn for the US-based company. ... BMS has agreed to buy Cardioxyl Pharma in a transaction valued at up to $2bn that would give it rights to a heart failure drug in phase II trials.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics